Lipocine Inc
NASDAQ:LPCN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lipocine Inc
NASDAQ:LPCN
|
US |
|
Stora Enso Oyj
F:ENUA
|
FI |
|
Insmed Inc
NASDAQ:INSM
|
US |
|
Select Medical Holdings Corp
NYSE:SEM
|
US |
|
C
|
Cohort PLC
XBER:C7K
|
UK |
Wall St Price Targets
LPCN Price Targets Summary
Lipocine Inc
According to Wall Street analysts, the average 1-year price target for
LPCN is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LPCN's stock price target?
Price Target
6.12
USD
According to Wall Street analysts, the average 1-year price target for
LPCN is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.
What is the Revenue forecast for Lipocine Inc?
Projected CAGR
112%
The compound annual growth rate for Revenue over the next 5 years is 112%.